TD Securities (USA)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$16K Buy
220
+1
+0.5% +$76 0.15% 57
2015
Q4
$18K Sell
219
-339
-61% -$28.1K 0.16% 53
2015
Q3
$47K Sell
558
-394,949
-100% -$33.3M 0.43% 52
2015
Q2
$33M Buy
395,507
+44,254
+13% +$3.37M 0.45% 53
2015
Q1
$25.5M Sell
351,253
-20,817
-6% -$1.48M 0.38% 59
2014
Q4
$25.7M Buy
372,070
+28,146
+8% +$1.9M 0.37% 63
2014
Q3
$22.3M Sell
343,924
-454
-0.1% -$28.7K 0.36% 62
2014
Q2
$21.4M Buy
344,378
+21,026
+7% +$1.25M 0.34% 71
2014
Q1
$19M Sell
323,352
-26,445
-8% -$1.48M 0.34% 71
2013
Q4
$17.8M Buy
349,797
+10,342
+3% +$518K 0.3% 79
2013
Q3
$17.1M Buy
339,455
+1,425
+0.4% +$74.6K 0.33% 76
2013
Q2
$16.6M Buy
+338,030
New +$18.4M 0.33% 73

Other funds holding LLY

TD Securities (USA)'s LLY Position: Q1 2016 in Review

TD Securities (USA) increased its Eli Lilly (LLY) stake by 0.46% in Q1 2016, buying an estimated $76 and bringing the position to 220 shares worth $16K. The position accounts for 0.15% of the portfolio, ranked #57.

TD Securities (USA) first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $33M in Q2 2015. 1,152 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • TD Securities (USA) held 220 shares of Eli Lilly worth $16K as of Q1 2016.
  • TD Securities (USA) bought 1 Eli Lilly share in Q1 2016, an estimated $76.
  • Eli Lilly made up 0.15% of TD Securities (USA)'s portfolio in Q1 2016, its #57 holding.
  • TD Securities (USA) first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Eli Lilly position peaked at $33M in Q2 2015.
  • 1,152 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.